Foley Senior Counsel R. Brian McCaslin authored an article titled “Are Patent Offices Ready for Personalized Medicine?” in the March/April 2009 issue of Bio-IT World. McCaslin discusses the unique challenges to the patent system presented by new sciences such as personalized medicine, stating that innovators seeking to patent new sciences should consider adapting their prosecution strategy to the current administrative landscape. He adds that innovators should consider postponing the filing date of an application until more information about the new science can be obtained.
Related Insights
13 December 2024
Events
Korean Startups & Entrepreneurs: Innovation Weekend
Join Foley & Lardner, the host and sponsor, on December 13th for Day 1 of the KSE Innovation Weekend, dedicated to empowering founders and aspiring entrepreneurs.
08 January 2025
Events
Whistleblower Protections: Navigating Health Care Employment & Labor Rights
Events in our recent history — the COVID-19 pandemic, increase in financial incentives for whistleblowers, and expansion of laws providing whistleblower procedures — have resulted in a spike in the number of whistleblower complaints received by regulators and employers globally.
12 December 2024
Blogs
Stellantis and UAW File Dueling Motions to Consolidate String of Lawsuits Regarding Strike Threats on Opposite Coasts
The nationwide fight continues between Chrysler owner Stellantis and the United Auto Workers Union (“UAW”) and its local chapters regarding the UAW’s threats to strike if Stellantis does not move forward with planned investment in its U.S. operations.